Published: 30 Jun 2022 | Report Code: 10248561 | Pages: 99
Asia Pacific Pain Management Devices Market will grow by 9.7% annually with a total addressable market cap of $16,238.7 million over 2022-2031, driven by the growing demand for chronic pain management among the geriatric population, the increasing availability of technically advanced pain management devices, supportive reimbursement policies and adverse effects of pain medications, and the growing awareness of pain management devices. Highlighted with 33 tables and 47 figures, this 100-page report “Asia Pacific Pain Management Devices Market 2021-2031 by Product (Neuromodulation & Neurostimulation Devices, Analgesic Infusion Pumps, Ablation Devices), Application (Neuropathic Pain, Musculoskeletal Pain, Cancer Pain, Facial & Migraine Pain, Others), Mode of Purchase (Prescription, OTC), and Country: Trend Forecast and Growth Opportunity” is based on a comprehensive research of the entire Asia Pacific Pain Management Devices Market and all its sub-segments through extensively detailed classifications.
Profound analysis and assessment are generated from premium primary and secondary information sources with inputs derived from industry professionals across the value chain. The report is based on studies on 2018-2021 and provides forecast from 2022 till 2031 with 2021 as the base year. (Please note: The report will be updated before delivery so that the latest historical year is the base year and the forecast covers at least 5 years over the base year.)
In-depth qualitative analyses include identification and investigation of the following aspects:
• Market Structure
• Growth Drivers
• Restraints and Challenges
• Emerging Product Trends & Market Opportunities
• Porter’s Five Forces
The trend and outlook of Asia Pacific market is forecast in optimistic, balanced, and conservative view by taking into account of COVID-19 and Russia-Ukraine conflict. The balanced (most likely) projection is used to quantify Asia Pacific pain management devices market in every aspect of the classification from perspectives of Product, Application, Mode of Purchase, and Country.
Based on Product, the Asia Pacific market is segmented into the following sub-markets with annual revenue ($ mn) for 2021-2031 included in each section.
• Neuromodulation & Neurostimulation Devices
o Spinal Cord Stimulators
o Transcutaneous Electrical Nerve Stimulation (TENS) Devices
o Sacral Nerve Stimulators
o Deep Brain Stimulators
o Other Neuromodulation & Neurostimulation Devices
• Analgesic Infusion Pumps
o External Infusion Pumps
o Intrathecal Infusion Pumps
• Ablation Devices
o Radiofrequency Ablation Devices
o Cryoablation Devices
Based on Application, the Asia Pacific market is segmented into the following sub-markets with annual revenue ($ mn) for 2021-2031 included in each section.
• Neuropathic Pain
• Musculoskeletal Pain
• Cancer Pain
• Facial & Migraine Pain
• Other Applications
By Mode of Purchase, the Asia Pacific market is segmented into the following sub-markets with annual revenue ($ mn) for 2021-2031 included in each section.
• Prescription
• Over-the-counter (OTC)
Geographically, the following national/local markets are fully investigated:
• Japan
• China
• South Korea
• Australia
• India
• Rest of APAC (further segmented into Malaysia, Singapore, Indonesia, Thailand, New Zealand, Vietnam, Taiwan, and Philippines)
For each key country, detailed analysis and data for annual revenue ($ mn) are available for 2021-2031. The breakdown of national markets by Product, Application and Mode of Purchase over the forecast years are also included. The report also covers current competitive scenario and the predicted trend; and profiles key vendors including market leaders and important emerging players.
Selected Key Players:
Abbott Laboratories
B. Braun Melsungen AG
Baxter International Inc.
Becton, Dickinson and Company
Boston Scientific Corp.
Colfax Corporation (DJO Global LLC)
Johnson & Johnson (Codman and Shurtleff, Inc.)
Kimberly Clark Corporation
Medtronic Plc.
Nevro Corp
Pfizer, Inc.
Smiths Medical, Inc.
Stryker Corp.
(Please note: The report will be updated before delivery so that the latest historical year is the base year and the forecast covers at least 5 years over the base year.)
Table of Contents: 1 Introduction 6 1.1 Industry Definition and Research Scope 6 1.1.1 Industry Definition 6 1.1.2 Research Scope 7 1.2 Research Methodology 10 1.2.1 Overview of Market Research Methodology 10 1.2.2 Market Assumption 11 1.2.3 Secondary Data 11 1.2.4 Primary Data 11 1.2.5 Data Filtration and Model Design 12 1.2.6 Market Size/Share Estimation 13 1.2.7 Research Limitations 14 1.3 Executive Summary 15 2 Market Overview and Dynamics 17 2.1 Market Size and Forecast 17 2.1.1 Impact of COVID-19 on World Economy 18 2.1.2 Impact of COVID-19 on the Market 20 2.2 Major Growth Drivers 22 2.3 Market Restraints and Challenges 28 2.4 Emerging Opportunities and Market Trends 31 2.5 Porter’s Fiver Forces Analysis 35 3 Segmentation of Asia Pacific Market by Product 39 3.1 Market Overview by Product 39 3.2 Neuromodulation & Neurostimulation Devices 41 3.2.1 Spinal Cord Stimulators 43 3.2.2 Transcutaneous Electrical Nerve Stimulation (TENS) Devices 44 3.2.3 Sacral Nerve Stimulators 45 3.2.4 Deep Brain Stimulators 46 3.2.5 Other Neuromodulation & Neurostimulation Devices 47 3.3 Analgesic Infusion Pumps 48 3.3.1 External Infusion Pumps 49 3.3.2 Intrathecal Infusion Pumps 50 3.4 Ablation Devices 51 3.4.1 Radiofrequency Ablation Devices 52 3.4.2 Cryoablation Devices 53 4 Segmentation of Asia Pacific Market by Application 54 4.1 Market Overview by Application 54 4.2 Neuropathic Pain 56 4.3 Musculoskeletal Pain 57 4.4 Cancer Pain 58 4.5 Facial & Migraine Pain 59 4.6 Other Applications 60 5 Segmentation of Asia Pacific Market by Mode of Purchase 61 5.1 Market Overview by Mode of Purchase 61 5.2 Prescription 63 5.3 Over-the-counter (OTC) 64 6 Asia-Pacific Market 2021-2031 by Country 65 6.1 Overview of Asia-Pacific Market 65 6.2 Japan 68 6.3 China 71 6.4 Australia 73 6.5 India 75 6.6 South Korea 77 6.7 Rest of APAC Region 79 7 Competitive Landscape 81 7.1 Overview of Key Vendors 81 7.2 New Product Launch, Partnership, Investment, and M&A 84 7.3 Company Profiles 85 Abbott Laboratories 85 B. Braun Melsungen AG 87 Baxter International Inc. 88 Becton, Dickinson and Company 89 Boston Scientific Corp. 90 Colfax Corporation (DJO Global LLC) 91 Johnson & Johnson (Codman and Shurtleff, Inc.) 92 Kimberly Clark Corporation 93 Medtronic Plc. 94 Nevro Corp 95 Pfizer, Inc. 96 Smiths Medical, Inc. 97 Stryker Corp. 98 RELATED REPORTS 99
List of Tables: Table 1. Snapshot of Asia Pacific Pain Management Devices Market in Balanced Perspective, 2021-2031 16 Table 2. World Economic Outlook, 2021-2031 19 Table 3. World Health Spending by Region, $ bn, 2013-2020 27 Table 4. Main Product Trends and Market Opportunities in Asia Pacific Pain Management Devices Market 31 Table 5. Asia Pacific Pain Management Devices Market by Product, 2021-2031, $ mn 39 Table 6. Asia Pacific Pain Management Devices Market: Neuromodulation & Neurostimulation Devices by Type, 2021-2031, $ mn 42 Table 7. Asia Pacific Pain Management Devices Market: Analgesic Infusion Pumps by Type, 2021-2031, $ mn 48 Table 8. Asia Pacific Pain Management Devices Market: Ablation Devices by Type, 2021-2031, $ mn 51 Table 9. Asia Pacific Pain Management Devices Market by Application, 2021-2031, $ mn 54 Table 10. Asia Pacific Pain Management Devices Market by Mode of Purchase, 2021-2031, $ mn 61 Table 11. APAC Pain Management Devices Market by Country, 2021-2031, $ mn 66 Table 12. Japan Pain Management Devices Market by Product, 2021-2031, $ mn 70 Table 13. Japan Pain Management Devices Market by Application, 2021-2031, $ mn 70 Table 14. Japan Pain Management Devices Market by Mode of Purchase, 2021-2031, $ mn 70 Table 15. China Pain Management Devices Market by Product, 2021-2031, $ mn 72 Table 16. China Pain Management Devices Market by Application, 2021-2031, $ mn 72 Table 17. China Pain Management Devices Market by Mode of Purchase, 2021-2031, $ mn 72 Table 18. Australia Pain Management Devices Market by Product, 2021-2031, $ mn 74 Table 19. Australia Pain Management Devices Market by Application, 2021-2031, $ mn 74 Table 20. Australia Pain Management Devices Market by Mode of Purchase, 2021-2031, $ mn 74 Table 21. India Pain Management Devices Market by Product, 2021-2031, $ mn 76 Table 22. India Pain Management Devices Market by Application, 2021-2031, $ mn 76 Table 23. India Pain Management Devices Market by Mode of Purchase, 2021-2031, $ mn 76 Table 24. South Korea Pain Management Devices Market by Product, 2021-2031, $ mn 78 Table 25. South Korea Pain Management Devices Market by Application, 2021-2031, $ mn 78 Table 26. South Korea Pain Management Devices Market by Mode of Purchase, 2021-2031, $ mn 78 Table 27. Pain Management Devices Market in Rest of APAC by Country/Region, 2021-2031, $ mn 80 Table 28. Abbott Laboratories: Company Snapshot 85 Table 29. Abbott Laboratories: Business Segmentation 86 Table 30. Abbott Laboratories: Product Portfolio 86
List of Figures: Figure 1. Research Method Flow Chart 10 Figure 2. Bottom-up Approach and Top-down Approach for Market Estimation 13 Figure 3. Asia Pacific Market Forecast in Optimistic, Conservative and Balanced Perspectives, 2021-2031 15 Figure 4. Asia Pacific Pain Management Devices Market, 2021-2031, $ mn 17 Figure 5. Impact of COVID-19 on Business 20 Figure 6. Primary Drivers and Impact Factors of Asia Pacific Pain Management Devices Market 22 Figure 7. Leading Causes of Death in the World, 2019-2020, million 25 Figure 8. Worldwide Geriatric Population (60 years and above) by Regions, 2015 & 2030, million 26 Figure 9. World Population 65 and Over, % of Total Population, 1950-2060 26 Figure 10. Primary Restraints and Impact Factors of Asia Pacific Pain Management Devices Market 28 Figure 11. Investment Opportunity Analysis 32 Figure 12. Porter’s Fiver Forces Analysis of Asia Pacific Pain Management Devices Market 35 Figure 13. Breakdown of Asia Pacific Pain Management Devices Market by Product, 2021-2031, % of Revenue 40 Figure 14. Asia Pacific Addressable Market Cap in 2022-2031 by Product, Value ($ mn) and Share (%) 40 Figure 15. Asia Pacific Pain Management Devices Market by Product: Neuromodulation & Neurostimulation Devices, 2021-2031, $ mn 41 Figure 16. Asia Pacific Pain Management Devices Market by Neuromodulation & Neurostimulation Devices: Spinal Cord Stimulators, 2021-2031, $ mn 43 Figure 17. Asia Pacific Pain Management Devices Market by Neuromodulation & Neurostimulation Devices: Transcutaneous Electrical Nerve Stimulation (TENS) Devices, 2021-2031, $ mn 44 Figure 18. Asia Pacific Pain Management Devices Market by Neuromodulation & Neurostimulation Devices: Sacral Nerve Stimulators, 2021-2031, $ mn 45 Figure 19. Asia Pacific Pain Management Devices Market by Neuromodulation & Neurostimulation Devices: Deep Brain Stimulators, 2021-2031, $ mn 46 Figure 20. Asia Pacific Pain Management Devices Market by Neuromodulation & Neurostimulation Devices: Other Neuromodulation & Neurostimulation Devices, 2021-2031, $ mn 47 Figure 21. Asia Pacific Pain Management Devices Market by Product: Analgesic Infusion Pumps, 2021-2031, $ mn 48 Figure 22. Asia Pacific Pain Management Devices Market by Analgesic Infusion Pumps: External Infusion Pumps, 2021-2031, $ mn 49 Figure 23. Asia Pacific Pain Management Devices Market by Analgesic Infusion Pumps: Intrathecal Infusion Pumps, 2021-2031, $ mn 50 Figure 24. Asia Pacific Pain Management Devices Market by Product: Ablation Devices, 2021-2031, $ mn 51 Figure 25. Asia Pacific Pain Management Devices Market by Ablation Devices: Radiofrequency Ablation Devices, 2021-2031, $ mn 52 Figure 26. Asia Pacific Pain Management Devices Market by Ablation Devices: Cryoablation Devices, 2021-2031, $ mn 53 Figure 27. Breakdown of Asia Pacific Pain Management Devices Market by Application, 2021-2031, % of Sales Revenue 55 Figure 28. Asia Pacific Addressable Market Cap in 2022-2031 by Application, Value ($ mn) and Share (%) 55 Figure 29. Asia Pacific Pain Management Devices Market by Application: Neuropathic Pain, 2021-2031, $ mn 56 Figure 30. Asia Pacific Pain Management Devices Market by Application: Musculoskeletal Pain, 2021-2031, $ mn 57 Figure 31. Asia Pacific Pain Management Devices Market by Application: Cancer Pain, 2021-2031, $ mn 58 Figure 32. Asia Pacific Pain Management Devices Market by Application: Facial & Migraine Pain, 2021-2031, $ mn 59 Figure 33. Asia Pacific Pain Management Devices Market by Application: Other Applications, 2021-2031, $ mn 60 Figure 34. Breakdown of Asia Pacific Pain Management Devices Market by Mode of Purchase, 2021-2031, % of Sales Revenue 62 Figure 35. Asia Pacific Addressable Market Cap in 2022-2031 by Mode of Purchase, Value ($ mn) and Share (%) 62 Figure 36. Asia Pacific Pain Management Devices Market by Mode of Purchase: Prescription, 2021-2031, $ mn 63 Figure 37. Asia Pacific Pain Management Devices Market by Mode of Purchase: Over-the-counter (OTC), 2021-2031, $ mn 64 Figure 38. Breakdown of APAC Pain Management Devices Market by Country, 2021 and 2031, % of Revenue 66 Figure 39. Contribution to APAC 2022-2031 Cumulative Market by Country, Value ($ mn) and Share (%) 67 Figure 40. Pain Management Devices Market in Japan, 2021-2031, $ mn 69 Figure 41. Pain Management Devices Market in China, 2021-2031, $ mn 71 Figure 42. Pain Management Devices Market in Australia, 2021-2031, $ mn 73 Figure 43. Pain Management Devices Market in India, 2021-2031, $ mn 75 Figure 44. Pain Management Devices Market in South Korea, 2021-2031, $ mn 77 Figure 45. Pain Management Devices Market in Rest of APAC, 2021-2031, $ mn 79 Figure 46. Growth Stage of Asia Pacific Pain Management Devices Industry over the Forecast Period 81
Selected Key Players: Abbott Laboratories B. Braun Melsungen AG Baxter International Inc. Becton, Dickinson and Company Boston Scientific Corp. Colfax Corporation (DJO Global LLC) Johnson & Johnson (Codman and Shurtleff, Inc.) Kimberly Clark Corporation Medtronic Plc. Nevro Corp Pfizer, Inc. Smiths Medical, Inc. Stryker Corp. (Please note: The report will be updated before delivery so that the latest historical year is the base year and the forecast covers at least 5 years over the base year.)